Axogen (AXGN) Non-Current Assets (2010 - 2026)
Axogen's (AXGN) quarterly Non-Current Assets came in at $104.8 million in Q1 2026, up 1.63% year-on-year from $103.1 million in Q1 2025, and up 3.47% quarter-over-quarter from $101.3 million in Q4 2025.
Axogen (AXGN) Non-Current Assets (2010 - 2026) Analysis & Trends
Axogen's Non-Current Assets history runs 17 years deep, the most recent figure standing at $104.8 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 1.63% year-over-year to $104.8 million in Q1 2026; TTM through Mar 2026 was $410.0 million, a 2.38% decrease from a year earlier, with the FY2025 full-year figure at $101.3 million, down 3.11% from the prior year.
- Non-Current Assets improved to $104.8 million in Q1 2026 per AXGN's latest filing, from $101.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $108.8 million in Q4 2023 and bottomed at $85.6 million in Q1 2022.
- The 5-year median for Non-Current Assets is $103.1 million (2025), against an average of $101.5 million.
- Across the five-year window, Non-Current Assets jumped 37.49% in 2022 and declined 4.41% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $97.3 million in 2022, then advanced by 11.83% to $108.8 million in 2023, then slipped by 3.96% to $104.5 million in 2024, then slipped by 3.11% to $101.3 million in 2025, then gained by 3.47% to $104.8 million in 2026.
- Per Business Quant, the three latest AXGN Non-Current Assets figures stand at $104.8 million (Q1 2026), $101.3 million (Q4 2025), and $101.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 104.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.78 Mn |
| Dec 31, 2025 | 101.27 Mn |
| Sep 30, 2025 | 101.94 Mn |
| Jun 30, 2025 | 102.03 Mn |
| Mar 31, 2025 | 103.10 Mn |
| Dec 31, 2024 | 104.51 Mn |
| Sep 30, 2024 | 105.73 Mn |
| Jun 30, 2024 | 106.67 Mn |
| Mar 31, 2024 | 107.85 Mn |
| Dec 31, 2023 | 108.82 Mn |
| Sep 30, 2023 | 107.19 Mn |
| Jun 30, 2023 | 105.47 Mn |
| Mar 31, 2023 | 100.78 Mn |
| Dec 31, 2022 | 97.31 Mn |
| Sep 30, 2022 | 93.07 Mn |
| Jun 30, 2022 | 89.31 Mn |
| Mar 31, 2022 | 85.55 Mn |
| Dec 31, 2021 | 80.98 Mn |
| Sep 30, 2021 | 75.00 Mn |
| Jun 30, 2021 | 68.74 Mn |